# MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer

> **NCT02582931** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 10 (actual)

## Conditions studied

- Cancer of Ovary
- Cancer of the Ovary
- Neoplasms, Ovarian
- Ovarian Cancer
- Ovary Cancer
- Ovary Neoplasms

## Interventions

- **DEVICE:** MRI-guided SBRT
- **BEHAVIORAL:** EORTC QLQ-C30 Questionnaire
- **BEHAVIORAL:** EORTC QLQ-OV28 Questionnaire

## Key facts

- **NCT ID:** NCT02582931
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-02
- **Primary completion:** 2018-05-14
- **Final completion:** 2018-12-13
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582931, "MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02582931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*